chr12-21536948-T-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_021957.4(GYS2):​c.*6A>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.391 in 1,580,222 control chromosomes in the GnomAD database, including 126,752 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 9369 hom., cov: 32)
Exomes 𝑓: 0.40 ( 117383 hom. )

Consequence

GYS2
NM_021957.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.0150
Variant links:
Genes affected
GYS2 (HGNC:4707): (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
SPX (HGNC:28139): (spexin hormone) The protein encoded by this gene is a hormone involved in modulation of cardiovascular and renal function. It has also been shown in rats to cause weight loss. Several transcript variants have been found for this gene. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 12-21536948-T-A is Benign according to our data. Variant chr12-21536948-T-A is described in ClinVar as [Benign]. Clinvar id is 261460.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21536948-T-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.515 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GYS2NM_021957.4 linkuse as main transcriptc.*6A>T 3_prime_UTR_variant 16/16 ENST00000261195.3
LOC124902896XR_007063240.1 linkuse as main transcriptn.519-98T>A intron_variant, non_coding_transcript_variant
GYS2XM_006719063.4 linkuse as main transcriptc.*6A>T 3_prime_UTR_variant 15/15
GYS2XM_024448960.2 linkuse as main transcriptc.*6A>T 3_prime_UTR_variant 16/17

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GYS2ENST00000261195.3 linkuse as main transcriptc.*6A>T 3_prime_UTR_variant 16/161 NM_021957.4 P1
SPXENST00000537527.1 linkuse as main transcriptn.472-98T>A intron_variant, non_coding_transcript_variant 3
SPXENST00000649016.1 linkuse as main transcriptn.529-98T>A intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.320
AC:
48646
AN:
151970
Hom.:
9375
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.104
Gnomad AMI
AF:
0.259
Gnomad AMR
AF:
0.471
Gnomad ASJ
AF:
0.372
Gnomad EAS
AF:
0.502
Gnomad SAS
AF:
0.534
Gnomad FIN
AF:
0.362
Gnomad MID
AF:
0.326
Gnomad NFE
AF:
0.380
Gnomad OTH
AF:
0.342
GnomAD3 exomes
AF:
0.415
AC:
104032
AN:
250832
Hom.:
23568
AF XY:
0.418
AC XY:
56646
AN XY:
135560
show subpopulations
Gnomad AFR exome
AF:
0.0919
Gnomad AMR exome
AF:
0.579
Gnomad ASJ exome
AF:
0.364
Gnomad EAS exome
AF:
0.509
Gnomad SAS exome
AF:
0.524
Gnomad FIN exome
AF:
0.366
Gnomad NFE exome
AF:
0.381
Gnomad OTH exome
AF:
0.396
GnomAD4 exome
AF:
0.398
AC:
568520
AN:
1428134
Hom.:
117383
Cov.:
26
AF XY:
0.401
AC XY:
285734
AN XY:
712528
show subpopulations
Gnomad4 AFR exome
AF:
0.0884
Gnomad4 AMR exome
AF:
0.573
Gnomad4 ASJ exome
AF:
0.368
Gnomad4 EAS exome
AF:
0.528
Gnomad4 SAS exome
AF:
0.522
Gnomad4 FIN exome
AF:
0.368
Gnomad4 NFE exome
AF:
0.389
Gnomad4 OTH exome
AF:
0.387
GnomAD4 genome
AF:
0.320
AC:
48649
AN:
152088
Hom.:
9369
Cov.:
32
AF XY:
0.327
AC XY:
24316
AN XY:
74354
show subpopulations
Gnomad4 AFR
AF:
0.104
Gnomad4 AMR
AF:
0.472
Gnomad4 ASJ
AF:
0.372
Gnomad4 EAS
AF:
0.502
Gnomad4 SAS
AF:
0.532
Gnomad4 FIN
AF:
0.362
Gnomad4 NFE
AF:
0.380
Gnomad4 OTH
AF:
0.344
Alfa
AF:
0.360
Hom.:
3484
Bravo
AF:
0.318
Asia WGS
AF:
0.501
AC:
1737
AN:
3478
EpiCase
AF:
0.376
EpiControl
AF:
0.366

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Glycogen storage disorder due to hepatic glycogen synthase deficiency Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicOct 23, 2015- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
2.4
DANN
Benign
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10431213; hg19: chr12-21689882; API